LM985 exhibits antitumor activity; it shows inhibitory effects against MAC13 cells in vitro (with MAC15A cells being less sensitive); in vivo, it demonstrates moderate activity against MAC13 at 200 mg/kg (s.c.), and repeated administration over 7 days significantly enhances its antitumor response.